MedTrace Logo

Peripheral Helper T-cells in Common Variable ImmunoDeficiency

NCT07255157 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-10

No results posted yet for this study

Summary

The aim is to determine whether whether Tph could support non-infectious complications through providing help to pathological B-cells.

Conditions

  • Common Variable Immunodeficiency

Interventions

OTHER

blood sample

48 ml whole blood for Peripheral blood mononuclear cell (PBMC) and serum isolation

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Jean-François VIALLARD, Prof · University Hospital, Bordeaux

  • Jonathan VISENTIN, Prof · University Hospital, Bordeaux

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07255157 on ClinicalTrials.gov